| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Nov 21, 2025 | Disposed to issuer(D) | 45K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 24K | — | — | 24K |
| Nov 21, 2025 | Disposed to issuer(D) | 24K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 155K | — | — | 155K |
| Nov 21, 2025 | Disposed to issuer(D) | 155K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 925K | — | $0 | 925K |
| Nov 21, 2025 | Grant(A) | 300K | — | — | 300K |
| Nov 21, 2025 | Disposed to issuer(D) | 300K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 150K | — | — | 150K |
| Nov 21, 2025 | Disposed to issuer(D) | 150K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 117K | — | — | 117K |
| Nov 21, 2025 | Disposed to issuer(D) | 117K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 20K | — | — | 20K |
| Nov 21, 2025 | Disposed to issuer(D) | 20K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 45K | — | — | 45K |
| Nov 21, 2025 | Disposed to issuer(D) | 37K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 37K | — | — | 37K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-297204) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Xilio Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.